Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcatheter Aortic Valve Replacement for Pure Severe Aortic Valve Regurgitation: a Real-world, Prospective, Multicenter Study (TRUST TAVR Registry)

NCT06381271 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT06381271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06381271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcatheter Aortic Valve Replacement for Pure Severe Aortic Valve Regurgitation: a Real-world, Prospective, Multicenter Study (TRUST TAVR Registry)
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Recruiting
Start date
October 30, 2018
Completion date
October 31, 2034
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve regurgitation